197 related articles for article (PubMed ID: 1406656)
1. Regulation of collagen I gene expression by ras.
Slack JL; Parker MI; Robinson VR; Bornstein P
Mol Cell Biol; 1992 Oct; 12(10):4714-23. PubMed ID: 1406656
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional repression of the alpha 1(I) collagen gene by ras is mediated in part by an intronic AP1 site.
Slack JL; Parker MI; Bornstein P
J Cell Biochem; 1995 Jul; 58(3):380-92. PubMed ID: 7593259
[TBL] [Abstract][Full Text] [Related]
3. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of the promoter and first intron of the human lysyl oxidase gene.
Csiszar K; Entersz I; Trackman PC; Samid D; Boyd CD
Mol Biol Rep; 1996; 23(2):97-108. PubMed ID: 8983023
[TBL] [Abstract][Full Text] [Related]
5. Coordinate regulation of the levels of type III and type I collagen mRNA in most but not all mouse fibroblasts.
Liau G; Yamada Y; de Crombrugghe B
J Biol Chem; 1985 Jan; 260(1):531-6. PubMed ID: 2981217
[TBL] [Abstract][Full Text] [Related]
6. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
[TBL] [Abstract][Full Text] [Related]
7. Estrogen inducibility of c-Ha-ras transcription in breast cancer cells. Identification of functional estrogen-responsive transcriptional regulatory elements in exon 1/intron 1 of the c-Ha-ras gene.
Pethe V; Shekhar PV
J Biol Chem; 1999 Oct; 274(43):30969-78. PubMed ID: 10521493
[TBL] [Abstract][Full Text] [Related]
8. Suppression of tumorigenicity in Ras-transformed fibroblasts by alpha 2(I) collagen.
Travers H; French NS; Norton JD
Cell Growth Differ; 1996 Oct; 7(10):1353-60. PubMed ID: 8891339
[TBL] [Abstract][Full Text] [Related]
9. Suppression of ras-mediated transformation. Differential expression of genes encoding extracellular matrix proteins in normal, transformed and revertant cells.
Hajnal A; Klemenz R; Schäfer R
Adv Enzyme Regul; 1993; 33():267-80. PubMed ID: 8356912
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic inhibition of lysyl oxidase transcription after transformation by ras oncogene.
Contente S; Kenyon K; Sriraman P; Subramanyan S; Friedman RM
Mol Cell Biochem; 1999 Apr; 194(1-2):79-91. PubMed ID: 10391127
[TBL] [Abstract][Full Text] [Related]
11. Isolation of genes specifically expressed in flat revertant cells derived from activated ras-transformed NIH 3T3 cells by treatment with azatyrosine.
Krzyzosiak WJ; Shindo-Okada N; Teshima H; Nakajima K; Nishimura S
Proc Natl Acad Sci U S A; 1992 Jun; 89(11):4879-83. PubMed ID: 1594588
[TBL] [Abstract][Full Text] [Related]
12. ras downregulation of protein kinase C mRNA in C3H 10T1/2 fibroblasts.
Fernandes ER; Ashendel CL
Mol Carcinog; 1996 Sep; 17(1):23-34. PubMed ID: 8876672
[TBL] [Abstract][Full Text] [Related]
13. cph, a novel oncogene which cooperates with H-ras in the transformation of NIH3T3 fibroblasts.
Velasco JA; Castro R; Avila MA; Laborda J; DiPaolo JA; Cansado J; Notario V
Oncogene; 1994 Jul; 9(7):2065-9. PubMed ID: 8208552
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the promoter region of the human thrombospondin gene. DNA sequences within the first intron increase transcription.
Laherty CD; Gierman TM; Dixit VM
J Biol Chem; 1989 Jul; 264(19):11222-7. PubMed ID: 2544587
[TBL] [Abstract][Full Text] [Related]
15. [A study on alterations of gene expression in a flat revertant R1 from ras-oncogene transformed NIH/3T3 cells].
Müllauer L
Hokkaido Igaku Zasshi; 1993 Sep; 68(5):705-16. PubMed ID: 7693563
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling by DNA microarray analysis in mouse embryonic fibroblasts transformed by rasV12 mutated protein and the E1A oncogene.
Vasseur S; Malicet C; Calvo EL; Labrie C; Berthezene P; Dagorn JC; Iovanna JL
Mol Cancer; 2003 Mar; 2():19. PubMed ID: 12685932
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning and functional analysis of the promoter region of rat nonmuscle myosin heavy chain-B gene.
Yam JW; Chan KW; Li N; Hsiao WL
Biochem Biophys Res Commun; 2000 Oct; 276(3):1203-9. PubMed ID: 11027611
[TBL] [Abstract][Full Text] [Related]
19. Ribozymes designed to inhibit transformation of NIH3T3 cells by the activated c-Ha-ras gene.
Koizumi M; Kamiya H; Ohtsuka E
Gene; 1992 Aug; 117(2):179-84. PubMed ID: 1639266
[TBL] [Abstract][Full Text] [Related]
20. Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-Ras (Q61L) contributes to cell survival.
Xin H; Geng Y; Pramanik R; Choubey D
J Cell Biochem; 2003 Jan; 88(1):191-204. PubMed ID: 12461788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
